Thirty-six multiparous Holstein cows were assigned to one of three dietary levels of lasalocid· 0, 180, or 360 mg/hd/d in a completely randomized design Cows were assigned to treatments I wk postcalving and remained on treatment until II wk postcalving Basal diets were composed of ground corn, alfalfa hay, alfalfa haylage, corn silage, and soybean meal, fortified with vitamins and minerals as needed. All ingredients were ground and fed as a total mixed ration Daily rations were fed in two equal portions at 0500 and I 700 h at a rate to allow a 5- 10% refusal. Daily measurements included milk production and dry matter intake (OM 1). Milk composition (fat, protein, and somatic ii cells) was analyzed twice per week on Tuesdays and Fridays. Cow body weight (BW) and visual body condition were measured weekly. Production during previous lactation was used as a covariate in analyzing the data. Although milk production was not affected by dietary treatment, lasalocid tended to increase daily milk production by approximately 2.5 kg/d (P 13) at both the 180 and 360 mg/hd/d levels Percent milk fat and protein were not afl'ected by dietary lasalocid (P 84 and 78, respectively). Somatic cell count of the milk was not affected by dietary lasalocid (/' 17). Dietary lasalocid reduced DMI by approximately I 5 kg/d at both the 180 and 360 mg/hdld levels (P .02). At the 180 and 360 mg/hdld levels, lasalocid increased amount of milk produced per kg of DM consumed by 16 kg (I' 08). either BW (P 89) nor body condition (P = 90) were affected by dietary lasalocid at either level. No effect of treatments was observed on blood metabolites Glucose, nonesterified fatty acids, P-hydroxybutyrate, and cholesterol all tell within the normal ranges of blood serum.